Alkem Laboratories Ltd 2023 IR
The report highlights Alkem Laboratories Limited's achievements during the fiscal year 2022-23, marking its 50th year of operations. The company achieved a revenue of ‑115,993 million and a profit after tax of ‑9,842 million. It successfully expanded its domestic market share, outperforming the Indian Pharmaceutical Market with a secondary sales growth of 12.8%. Additionally, the company advanced its ESG initiatives, including planting over one million trees in drought-prone areas and establishing smart classes in government schools.
Company: Alkem Laboratories Ltd
Sector: Manufacturing
Country: India
Year: 2023
Type: IR
Pages: 276
Back to company
Alkem Laboratories Ltd
Annual Report
The report highlights Alkem Laboratories Limited's achievements during the fiscal year 2022-23, marking its 50th year of operations. The company achieved a revenue of ‑115,993 million and a profit after tax of ‑9,842 million. It successfully expanded its domestic market share, outperforming the Indian Pharmaceutical Market with a secondary sales growth of 12.8%. Additionally, the company advanced its ESG initiatives, including planting over one million trees in drought-prone areas and establishing smart classes in government schools.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees